Pin your most used calculators here by clicking the star in the dropdown.
Febrile Neutropenia Triage
Clinical Context & Background
This panel helps triage patients with chemotherapy-induced Febrile Neutropenia (FN).
1. MASCC Risk Index: The standard tool. Identifies "Low Risk" patients (Score ≥ 21) who may be eligible for home discharge.
2. CISNE Score: Specifically for patients with Solid Tumors who appear stable. A score of 0 indicates the highest safety for outpatient care.
Clinical Workflow:
If MASCC indicates Low Risk (≥21) AND CISNE indicates Low Risk (0), the patient is a strong candidate for outpatient management with oral antibiotics (e.g. Cipro/Augmentin), provided social support is adequate.
Reference Data
| Tool | Score | Interpretation |
|---|---|---|
| MASCC | ≥ 21 | Low Risk (Safe for Outpatient?) |
| MASCC | < 21 | High Risk (Admit for IV) |
| CISNE | 0 | Low Risk (Safe) |
| CISNE | 1 - 2 | Intermediate Risk (Observation?) |
| CISNE | ≥ 3 | High Risk (Admit) |
Related Tools
Evidence-based oncology decision support. Verify with clinical guidelines.